Lightpoint Medical Ltd

Lightpoint Medical Ltd, based in Amersham, UK, is a small, active company founded twelve years ago in 2012. With seven employees and £6,464,206 in assets, it operates from a real address and is overseen by two directors and one owner. The company is an irregular importer of electrical machinery and equipment, with just one month of import activity recorded in 01 October 2021, but a regular exporter of optical and medical tools and devices, with seven months of export activity.

The company's website highlights a transformation in cancer surgery, working at the intersection of surgery, AI, and nuclear imaging. Lightpoint Medical has been acquired by Telix Pharmaceuticals, and its technologies help surgeons detect cancer accurately in real time, advancing surgical precision and reducing costs. The website details a strong pipeline of innovative technologies and a focus on working alongside leading cancer centers and surgeons. A key offering is the SENSEI drop-in gamma probe, used in bladder cancer surgery and other procedures, and the company is actively involved in clinical studies and collaborations.

Financially, Lightpoint Medical Ltd’s recent report reveals some interesting trends. Cash reserves have increased dramatically by 3300%, reaching £4,700,000, while corporation tax payable has jumped to £410,000. Debtor levels have decreased by 32%, suggesting improved collection efforts, but creditors have also fallen by 37%. A significant shift is observed in equity, with net assets increasing by a remarkable 1200% to £29,000,000. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows for agility, but the large increase in equity could indicate a significant investment or acquisition. With no auditor mentioned (likely exempt as a small company), the figures rely on unaudited statements.

Overall, Lightpoint Medical Ltd appears to be a financially healthy company with a focus on innovation in cancer surgery. The acquisition by Telix Pharmaceuticals suggests a promising future, but the company’s long-term success will depend on its ability to continue developing and commercializing its technologies.

Registered in England/Wales under the registration number 08108247, with a registered address at HP7 0UT, England, Amersham, St Mary’S Court, The Broadway.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.